AJANTPHARM - IntraDay Trade Analysis with Live Signals

Last Updated Time : 19 Sept 25, 2:16 pm

IntraDay Trade Rating: 3.1

📊 Intraday Trading Analysis for AJANTPHARM (Ajanta Pharma Ltd.)

Ajanta Pharma shows mixed signals for intraday trading today. While its fundamentals are strong and valuation is reasonable, technical indicators suggest weak momentum and limited upside in the short term.

🔍 Technical & Momentum Overview

RSI at 44.0: Bearish-neutral — indicates lack of momentum and possible downside risk.

MACD at -21.8: Negative crossover — confirms short-term weakness.

Price Action

Trading below both 50 DMA (₹2,609) and 200 DMA (₹2,644) — bearish structure.

Current price ₹2,550 is near minor support but lacks breakout strength.

Volume

Today’s volume (47.2K) is slightly below 1-week average (49.2K) — fading interest.

52W Index at 36.6%: Trading in lower range — sentiment is weak.

Fundamentals

Strong ROCE (33.0%), ROE (25.7%), and EPS (₹74.9) — operational excellence.

Reasonable P/E (34.0) vs Industry PE (33.4) — fair valuation.

Low debt (0.01) and positive PAT growth (+8.02%) — sentiment support.

Flat FII/DII holdings — neutral institutional stance.

🎯 Trade Setup

If Entering Fresh Today

Buy Zone: ₹2,535–₹2,545 (near intraday support and slightly below current price)

Profit Target: ₹2,570–₹2,585 (resistance zone near 50 DMA)

Stop-Loss: ₹2,520 (below recent swing low)

If Already Holding

Exit on Strength

If price approaches ₹2,585+ and RSI crosses 48 — signals short-term recovery.

Volume spike above 55K confirms momentum — consider partial booking.

Exit on Weakness

If price drops below ₹2,520 with MACD widening negatively.

RSI falling below 42 — signals momentum breakdown.

🧠 Final Verdict

AJANTPHARM is not ideal for aggressive intraday trading, but can be considered for cautious scalping. Momentum is weak, and price action favors range-bound strategies. Tight risk management is essential.

Edit in a page